Business / Finance

RSS

YM BioSciences total revenue decreases to $1.5 million for fiscal 2011

YM BioSciences Inc., a drug development company advancing a diverse portfolio of promising hematology and cancer-related products, today reported operational and financial results for its 2011 fiscal year, ended June 30, 2011.

23 Sep 2011

MannKind proposes to offer senior secured discount notes due 2017

MannKind Corporation today announced that it proposes to offer, subject to market conditions, senior secured discount notes due 2017 expected to yield gross proceeds of approximately $370.0 million.

23 Sep 2011

UHC honors University of Mississippi Health Care with Supplier Diversity Leadership Award

For the first time, UHC has honored a member organization for the development and implementation of an outstanding supplier diversity program. Roberta Graham, UHC executive vice president, and Jake Groenewold, UHC senior vice president, Supply Chain, presented the Supplier Diversity Leadership Award to University of Mississippi Health Care at the UHC Annual Conference 2011 in Chicago on September 22.

23 Sep 2011

Rite Aid reports $6.3 billion revenues for second quarter ended August, 2011

Rite Aid Corporation today reported financial results for its fiscal second quarter ended August 27, 2011.

22 Sep 2011

Cambridge Heart enters agreement with EO Medical for MTWA technology

Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced that it has executed an exclusive agreement with EO Medical Pte Ltd to distribute its HearTwave II System and proprietary Microvolt T-Wave Alternans (MTWA) software and Micro-V Alternans Sensors in Singapore upon regulatory approval.

22 Sep 2011

Palatin's fourth quarter net loss decreases to $3.3 million

Palatin Technologies, Inc., a biopharmaceutical company developing bremelanotide for sexual dysfunction indications and PL-3994 for acute asthma and other indications, today announced results for its fourth quarter and fiscal year ended June 30, 2011.

22 Sep 2011

Zymeworks announces completion of $8.1M financing

Zymeworks Inc., a privately held biotherapeutics company focused on the development of best-in-class antibody and next generation protein-based therapeutics, today announced the completion of a financing totaling $8.1 million.

22 Sep 2011

OPTOS to acquire ophthalmic instrumentation business from OPKO

OPKO Health, Inc. has agreed to sell its ophthalmic instrumentation business to OPTOS, Inc., a subsidiary of Optos plc, a leading and rapidly growing medical technology company engaged in the design, development, manufacture and marketing of devices to image the retina of the eye. Optos will pay OPKO $17.5 million in cash at closing, plus future royalties.

22 Sep 2011

IRIDEX licenses rights to Ocunetics' intellectual property

IRIDEX Corporation today announced that it has exclusively licensed the rights to all of the intellectual property of Ocunetics, Inc., a privately held company based in Alamo, California. Ocunetics develops procedure-enabling medical devices that are intended to increase surgeons' efficiency, while improving case predictability for ophthalmic surgeries.

21 Sep 2011

Silence Therapeutics reports revenue of £354,078 for six months ended 30 June 2011

Silence Therapeutics Plc, a leading international RNAi therapeutics company, today provides a corporate update and announces its interim results for the six months ended 30 June 2011.

21 Sep 2011

Tokai raises $23M in Series D3 financing

Tokai Pharmaceuticals, a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that it has raised $23 million in a Series D3 financing.

20 Sep 2011

NanoViricides acquires light industrial building for laboratory facilities and cGMP production

NanoViricides, Inc. announced that Inno-Haven LLC has completed acquisition of a light industrial building. The Company anticipates that it will be leasing a portion of this space, in the near future, for laboratory facilities and cGMP production of its nanoviricides® drug candidates against various viral diseases.

19 Sep 2011

KYTHERA closes $37.4M Series D financing

KYTHERA Biopharmaceuticals, Inc., a privately-held biotechnology company focused on the development and commercialization of products in aesthetic medicine, today announced the closing of a $37.4M Series D financing.

19 Sep 2011

Alkermes establishes business operations in Ireland

Alkermes plc today announced the establishment of its corporate operations in Ireland, with new headquarters located in Dublin. The company, including its headquarters and operations in Athlone, County Westmeath, has more than 450 employees based in Ireland and more than 1,200 employees worldwide.

19 Sep 2011

MDC Partners acquires majority stake in Concentric Pharma Advertising

MDC Partners announced today that they have acquired a majority stake in leading healthcare and pharma advertising and marketing agency, Concentric Pharma Advertising.

17 Sep 2011

Radiology Associates of North Texas extends billing services contract with Zotec Partners

Zotec Partners, an industry leader in medical billing, practice management and Radiology Information Systems (RIS) software and services, announces today it has received a multi-year contract extension from Radiology Associates of North Texas, PA, formerly Radiology Associates of Tarrant County.

17 Sep 2011

Infrared Systems International is now AquaLiv Technologies

Infrared Systems International announced it has changed its name to AquaLiv Technologies, Inc. in order to better reflect its new corporate strategy. Along with the name change the company has been issued a new symbol by FINRA of AQLV.

17 Sep 2011

Topcon Europe Medical to distribute LensAR product line in Europe

Topcon Europe Medical BV and LensAR Inc announce their intent to enter into a long term strategic cooperation. Topcon Europe Medical BV will be responsible for the distribution and marketing the LensAR product line in Europe.

17 Sep 2011

Millennium ranked fifth among best biopharmaceutical companies in the world

Millennium: The Takeda Oncology Company today announced that Science magazine has named it among the best biopharmaceutical companies in the world for the fourth consecutive year. Each year Science conducts a survey to determine the top employers in the biotechnology, biopharmaceutical, pharmaceutical and related industries worldwide.

17 Sep 2011

LifePoint Hospitals' board authorizes new $250M stock repurchase program

LifePoint Hospitals, Inc. today announced that its Board of Directors, at a regularly scheduled meeting, has authorized a new stock repurchase program that will allow for repurchases of up to $250 million of its common stock over the next 18 months. Amounts available under the Company's previously announced share repurchase program were exhausted during the current fiscal quarter.

17 Sep 2011